U. S. Food and Drug Administration
Center for Food Safety and Applied Nutrition
September 30, 2002
Public Meeting: Assessing Acrylamide in the U.S. Food Supply
Major Components of FDA's Action Plan for Acrylamide
September 30, 2002
[Transcript of Dr. Canady's remarks]
Begin Presentation
Author:
Richard Canady, PhD DABT
Table of Contents
Major Components of FDA's Action Plan for Acrylamide
FDA assessment after press release by Sweden last April
Questions raised
Important to keep in mind
Overview of this presentation: Major components of the plan
Testing foods: General issues
1. Testing foods: Methods development
1. Testing foods: Sampling plan development
Testing foods: Overall level of sampling
1. Testing foods: Occurrence
1. Testing foods: Exposure
Total Diet Study component of FDA's acrylamide action plan
Collection Sequencing for TDS
FDA's Occurrence Data: Status
Recap: Testing for acrylamide
2. Acrylamide formation: Research and outreach
3. Toxicology: State of Knowledge
FDA's National Center for Toxicological Research (NCTR) short-term studies
FDA's National Center for Toxicological Research (NCTR) longer-term studies
3. Toxicology: Evaluation of noncancer endpoints
4. Education
5. Meetings and collaborative projects: FDA-sponsored
5. Meetings and collaborative projects: Consortia and symposia
5. Meetings and collaborative projects: International
Recap: Overall Goal
Interagency meeting on acrylamide toxicity/biomarker research
Agencies participating
Topics addressed
Additional goals of the meeting
Multiple collaborations and potential synergies identified
Next steps
Download presentation source
(PPT format)
Pesticides, Metals, Chemical Contaminants, & Natural Toxins
Foods Home
|
FDA Home
|
Search/Subject Index
|
Disclaimers & Privacy Policy
|
Accessibility/Help
Hypertext updated by las 2002-OCT-29